Company: SUPN
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042531
Chunk: 49

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 49
---
 share units vest depending upon the level of achievement of specified performance goals. Our other NEOs will only realize a portion of this compensation unless the stock awards comprised of performance share units vest, which is dependent upon the level of achievement of specified performance goals. For information regarding assumptions underlying the valuation of equity awards, see Note 9 to our consolidated financial statements included in our Annual Report to Stockholders. (2) Our NEOs will only realize compensation to the extent the market price of our common stock at date of exercise is greater than the exercise price of such stock options. For information regarding assumptions underlying the valuation of equity awards, see Note 9 to our consolidated financial statements included in our Annual Report to Stockholders. (3) Amounts represent annual performance bonus compensation earned for the years ended December 31, 2024, 2023 and 2022 based on pre-established performance objectives. Annual performance bonus compensation for 2024, 2023 and 2022 was paid in early 2025, early 2024 and early 2023, respectively. (4) Amounts include (i) the premium amounts paid by us for life insurance and short-term and long-term disability coverage for each NEO, (ii) the employer matching contributions made on behalf of each NEO to our 401(k) plan and (iii) the compensation expense related to participation in the Company’s ESPP for Drs. Bhatt and Rubin and Messrs. Dec and Mottola. Mr. Khattar’s other compensation also includes the value of certain expenses incurred in connection with participation by Mr. Khattar in the Company’s President’s Club award program for certain of the Company’s sales professionals, which was valued at $16,902 for fiscal year 2024. Drs. Bhatt and Rubin’s and Mr. Mottola’s other compensation also includes a reimbursement for certain membership fees of $300, $184 and $255 in the fiscal year 2024, respectively. In addition, Mr. Dec’s other compensation for fiscal year 2024 includes a grossed-up tenure award of $750 received in the fiscal year 2024. 33

Employment Agreement, Offer Letter and Severance Benefits Jack A. Khattar On December 22, 2005, we entered into an Employment Agreement with Mr. Khattar, our President and CEO, providing for his continued employment, effective as of the signing date. This employment agreement provides that Mr. Khattar’s employment is at-will